Emergent BioSolutions is a biotechnology company focused on developing and manufacturing high-quality medical countermeasures for infectious diseases, including vaccines and therapeutics
With an emphasis on public health, the company addresses a range of health threats, including those posed by bioterrorism, pandemic outbreaks, and antibiotic-resistant pathogens. Emergent works closely with government agencies and global health organizations to ensure preparedness against various health emergencies, leveraging advanced technologies and expertise in biopharmaceutical manufacturing to deliver effective solutions. Additionally, the company is involved in the production of specialty pharmaceutical products and provides contract development and manufacturing services to other organizations in the healthcare sector.
U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions.
Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January.
Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQNVDA) up 1.37% and Tesla, Inc. NASDAQ:TSLANASDAQTSLA)
UN calls for evidence-based, human rights-focused approach to drug policies, declaring the failed war on drugs needs to be abandoned. Urges transformative change and adoption of International Guidelines on Human Rights and Drug Policy.
